Brain and Other Nervous System Cancers | Did You Know?
Did you know that there were over 173,000 people living with brain and other nervous system cancers in the United States in 2018? Watch the Brain and Other N…
Did you know that there were over 173,000 people living with brain and other nervous system cancers in the United States in 2018? Watch the Brain and Other N…
Leland Metheny, MD, discusses ongoing clinical trials and their implications for the field of hematologic oncology.
Rebecca Klisovic, MD, discusses 4 case studies of patients who presented with varying types of myelofibrosis and the appropriate treatment avenues for each patient.
Analysis of long-term findings from the phase III Dana-Farber Cancer Institute Trial 05-043 showed that whole-pelvic radiation therapy was associated with favorable survival outcomes vs…
A phase 2 trial of stenoparib in advanced recurrent ovarian cancer has been closed early to enable a follow-on trial with FDA regulatory intent.
Patients with CLL/SLL who received second-line venetoclax experienced monthly cost savings compared with those who received a second-line BTK inhibitor.
Amandeep Salhotra, MD, discusses the feasibility and safety of Orca-T graft in patients undergoing allogeneic transplant for hematologic malignancies.
Miriam Margolyes shares how she changed her mind and learned that respecting people and making them feel accepted is important in life. #GrahamNortonShow #Gr…
Video abstract of “Cytolethal distending toxin B inoculation leads to distinct gut microtypes and IBS-D-like microRNA-mediated gene expression changes in a r…
An abstract is unavailable.
Even if you’re in remission or you show no evidence of disease, you may still have fears that cancer may return. We spoke with our…